purchase customization

1 Introduction to Research & Analysis Reports
1.1 Human Genetically Engineered Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Genetically Engineered Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Genetically Engineered Vaccine Overall Market Size
2.1 Global Human Genetically Engineered Vaccine Market Size: 2023 VS 2030
2.2 Global Human Genetically Engineered Vaccine Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Human Genetically Engineered Vaccine Sales: 2019-2030
3 Company Landscape
3.1 Top Human Genetically Engineered Vaccine Players in Global Market
3.2 Top Global Human Genetically Engineered Vaccine Companies Ranked by Revenue
3.3 Global Human Genetically Engineered Vaccine Revenue by Companies
3.4 Global Human Genetically Engineered Vaccine Sales by Companies
3.5 Global Human Genetically Engineered Vaccine Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Human Genetically Engineered Vaccine Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Human Genetically Engineered Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Human Genetically Engineered Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Human Genetically Engineered Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Human Genetically Engineered Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Human Genetically Engineered Vaccine Market Size Markets, 2023 & 2030
4.1.2 Genetic Recombinant Vaccine
4.1.3 Recombinant Subunit Vaccines
4.1.4 Genetic Vaccine
4.2 By Type - Global Human Genetically Engineered Vaccine Revenue & Forecasts
4.2.1 By Type - Global Human Genetically Engineered Vaccine Revenue, 2019-2024
4.2.2 By Type - Global Human Genetically Engineered Vaccine Revenue, 2025-2030
4.2.3 By Type - Global Human Genetically Engineered Vaccine Revenue Market Share, 2019-2030
4.3 By Type - Global Human Genetically Engineered Vaccine Sales & Forecasts
4.3.1 By Type - Global Human Genetically Engineered Vaccine Sales, 2019-2024
4.3.2 By Type - Global Human Genetically Engineered Vaccine Sales, 2025-2030
4.3.3 By Type - Global Human Genetically Engineered Vaccine Sales Market Share, 2019-2030
4.4 By Type - Global Human Genetically Engineered Vaccine Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Human Genetically Engineered Vaccine Market Size, 2023 & 2030
5.1.2 Hepatitis E
5.1.3 Human Papillomavirus (HPV)
5.1.4 Rotavirus
5.1.5 Others
5.2 By Application - Global Human Genetically Engineered Vaccine Revenue & Forecasts
5.2.1 By Application - Global Human Genetically Engineered Vaccine Revenue, 2019-2024
5.2.2 By Application - Global Human Genetically Engineered Vaccine Revenue, 2025-2030
5.2.3 By Application - Global Human Genetically Engineered Vaccine Revenue Market Share, 2019-2030
5.3 By Application - Global Human Genetically Engineered Vaccine Sales & Forecasts
5.3.1 By Application - Global Human Genetically Engineered Vaccine Sales, 2019-2024
5.3.2 By Application - Global Human Genetically Engineered Vaccine Sales, 2025-2030
5.3.3 By Application - Global Human Genetically Engineered Vaccine Sales Market Share, 2019-2030
5.4 By Application - Global Human Genetically Engineered Vaccine Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Human Genetically Engineered Vaccine Market Size, 2023 & 2030
6.2 By Region - Global Human Genetically Engineered Vaccine Revenue & Forecasts
6.2.1 By Region - Global Human Genetically Engineered Vaccine Revenue, 2019-2024
6.2.2 By Region - Global Human Genetically Engineered Vaccine Revenue, 2025-2030
6.2.3 By Region - Global Human Genetically Engineered Vaccine Revenue Market Share, 2019-2030
6.3 By Region - Global Human Genetically Engineered Vaccine Sales & Forecasts
6.3.1 By Region - Global Human Genetically Engineered Vaccine Sales, 2019-2024
6.3.2 By Region - Global Human Genetically Engineered Vaccine Sales, 2025-2030
6.3.3 By Region - Global Human Genetically Engineered Vaccine Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Human Genetically Engineered Vaccine Revenue, 2019-2030
6.4.2 By Country - North America Human Genetically Engineered Vaccine Sales, 2019-2030
6.4.3 US Human Genetically Engineered Vaccine Market Size, 2019-2030
6.4.4 Canada Human Genetically Engineered Vaccine Market Size, 2019-2030
6.4.5 Mexico Human Genetically Engineered Vaccine Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Human Genetically Engineered Vaccine Revenue, 2019-2030
6.5.2 By Country - Europe Human Genetically Engineered Vaccine Sales, 2019-2030
6.5.3 Germany Human Genetically Engineered Vaccine Market Size, 2019-2030
6.5.4 France Human Genetically Engineered Vaccine Market Size, 2019-2030
6.5.5 U.K. Human Genetically Engineered Vaccine Market Size, 2019-2030
6.5.6 Italy Human Genetically Engineered Vaccine Market Size, 2019-2030
6.5.7 Russia Human Genetically Engineered Vaccine Market Size, 2019-2030
6.5.8 Nordic Countries Human Genetically Engineered Vaccine Market Size, 2019-2030
6.5.9 Benelux Human Genetically Engineered Vaccine Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Human Genetically Engineered Vaccine Revenue, 2019-2030
6.6.2 By Region - Asia Human Genetically Engineered Vaccine Sales, 2019-2030
6.6.3 China Human Genetically Engineered Vaccine Market Size, 2019-2030
6.6.4 Japan Human Genetically Engineered Vaccine Market Size, 2019-2030
6.6.5 South Korea Human Genetically Engineered Vaccine Market Size, 2019-2030
6.6.6 Southeast Asia Human Genetically Engineered Vaccine Market Size, 2019-2030
6.6.7 India Human Genetically Engineered Vaccine Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Human Genetically Engineered Vaccine Revenue, 2019-2030
6.7.2 By Country - South America Human Genetically Engineered Vaccine Sales, 2019-2030
6.7.3 Brazil Human Genetically Engineered Vaccine Market Size, 2019-2030
6.7.4 Argentina Human Genetically Engineered Vaccine Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Human Genetically Engineered Vaccine Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Human Genetically Engineered Vaccine Sales, 2019-2030
6.8.3 Turkey Human Genetically Engineered Vaccine Market Size, 2019-2030
6.8.4 Israel Human Genetically Engineered Vaccine Market Size, 2019-2030
6.8.5 Saudi Arabia Human Genetically Engineered Vaccine Market Size, 2019-2030
6.8.6 UAE Human Genetically Engineered Vaccine Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Human Genetically Engineered Vaccine Major Product Offerings
7.1.4 Pfizer Human Genetically Engineered Vaccine Sales and Revenue in Global (2019-2024)
7.1.5 Pfizer Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck Human Genetically Engineered Vaccine Major Product Offerings
7.2.4 Merck Human Genetically Engineered Vaccine Sales and Revenue in Global (2019-2024)
7.2.5 Merck Key News & Latest Developments
7.3 GSK
7.3.1 GSK Company Summary
7.3.2 GSK Business Overview
7.3.3 GSK Human Genetically Engineered Vaccine Major Product Offerings
7.3.4 GSK Human Genetically Engineered Vaccine Sales and Revenue in Global (2019-2024)
7.3.5 GSK Key News & Latest Developments
7.4 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD.
7.4.1 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Company Summary
7.4.2 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Business Overview
7.4.3 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Human Genetically Engineered Vaccine Major Product Offerings
7.4.4 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Human Genetically Engineered Vaccine Sales and Revenue in Global (2019-2024)
7.4.5 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Key News & Latest Developments
7.5 Walvax Biotechnology Co., Ltd.
7.5.1 Walvax Biotechnology Co., Ltd. Company Summary
7.5.2 Walvax Biotechnology Co., Ltd. Business Overview
7.5.3 Walvax Biotechnology Co., Ltd. Human Genetically Engineered Vaccine Major Product Offerings
7.5.4 Walvax Biotechnology Co., Ltd. Human Genetically Engineered Vaccine Sales and Revenue in Global (2019-2024)
7.5.5 Walvax Biotechnology Co., Ltd. Key News & Latest Developments
7.6 Bharat Biotech
7.6.1 Bharat Biotech Company Summary
7.6.2 Bharat Biotech Business Overview
7.6.3 Bharat Biotech Human Genetically Engineered Vaccine Major Product Offerings
7.6.4 Bharat Biotech Human Genetically Engineered Vaccine Sales and Revenue in Global (2019-2024)
7.6.5 Bharat Biotech Key News & Latest Developments
7.7 Chengdu Kanghua Biological Products Co., Ltd.
7.7.1 Chengdu Kanghua Biological Products Co., Ltd. Company Summary
7.7.2 Chengdu Kanghua Biological Products Co., Ltd. Business Overview
7.7.3 Chengdu Kanghua Biological Products Co., Ltd. Human Genetically Engineered Vaccine Major Product Offerings
7.7.4 Chengdu Kanghua Biological Products Co., Ltd. Human Genetically Engineered Vaccine Sales and Revenue in Global (2019-2024)
7.7.5 Chengdu Kanghua Biological Products Co., Ltd. Key News & Latest Developments
7.8 South China Vaccine Corporation Limited
7.8.1 South China Vaccine Corporation Limited Company Summary
7.8.2 South China Vaccine Corporation Limited Business Overview
7.8.3 South China Vaccine Corporation Limited Human Genetically Engineered Vaccine Major Product Offerings
7.8.4 South China Vaccine Corporation Limited Human Genetically Engineered Vaccine Sales and Revenue in Global (2019-2024)
7.8.5 South China Vaccine Corporation Limited Key News & Latest Developments
7.9 Beijing Health Guard Biotechnology Inc.
7.9.1 Beijing Health Guard Biotechnology Inc. Company Summary
7.9.2 Beijing Health Guard Biotechnology Inc. Business Overview
7.9.3 Beijing Health Guard Biotechnology Inc. Human Genetically Engineered Vaccine Major Product Offerings
7.9.4 Beijing Health Guard Biotechnology Inc. Human Genetically Engineered Vaccine Sales and Revenue in Global (2019-2024)
7.9.5 Beijing Health Guard Biotechnology Inc. Key News & Latest Developments
7.10 CSL Limited
7.10.1 CSL Limited Company Summary
7.10.2 CSL Limited Business Overview
7.10.3 CSL Limited Human Genetically Engineered Vaccine Major Product Offerings
7.10.4 CSL Limited Human Genetically Engineered Vaccine Sales and Revenue in Global (2019-2024)
7.10.5 CSL Limited Key News & Latest Developments
7.11 Emergent BioSolutions
7.11.1 Emergent BioSolutions Company Summary
7.11.2 Emergent BioSolutions Human Genetically Engineered Vaccine Business Overview
7.11.3 Emergent BioSolutions Human Genetically Engineered Vaccine Major Product Offerings
7.11.4 Emergent BioSolutions Human Genetically Engineered Vaccine Sales and Revenue in Global (2019-2024)
7.11.5 Emergent BioSolutions Key News & Latest Developments
7.12 Sanofi Pasteur
7.12.1 Sanofi Pasteur Company Summary
7.12.2 Sanofi Pasteur Human Genetically Engineered Vaccine Business Overview
7.12.3 Sanofi Pasteur Human Genetically Engineered Vaccine Major Product Offerings
7.12.4 Sanofi Pasteur Human Genetically Engineered Vaccine Sales and Revenue in Global (2019-2024)
7.12.5 Sanofi Pasteur Key News & Latest Developments
7.13 Serum Institute
7.13.1 Serum Institute Company Summary
7.13.2 Serum Institute Human Genetically Engineered Vaccine Business Overview
7.13.3 Serum Institute Human Genetically Engineered Vaccine Major Product Offerings
7.13.4 Serum Institute Human Genetically Engineered Vaccine Sales and Revenue in Global (2019-2024)
7.13.5 Serum Institute Key News & Latest Developments
8 Global Human Genetically Engineered Vaccine Production Capacity, Analysis
8.1 Global Human Genetically Engineered Vaccine Production Capacity, 2019-2030
8.2 Human Genetically Engineered Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Human Genetically Engineered Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Human Genetically Engineered Vaccine Supply Chain Analysis
10.1 Human Genetically Engineered Vaccine Industry Value Chain
10.2 Human Genetically Engineered Vaccine Upstream Market
10.3 Human Genetically Engineered Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Human Genetically Engineered Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer